Search results for "depressive disorder"

showing 10 items of 445 documents

Increased blood mercury levels in patients with Alzheimer's disease.

1998

Alzheimer's disease (AD) is a common neurodegenerative disorder that leads to dementia and death. In addition to several genetic parameters, various environmental factors may influence the risk of getting AD. In order to test whether blood levels of the heavy metal mercury are increased in AD, we measured blood mercury concentrations in AD patients (n = 33), and compared them to age-matched control patients with major depression (MD) (n = 45), as well as to an additional control group of patients with various non-psychiatric disorders (n = 65). Blood mercury levels were more than two-fold higher in AD patients as compared to both control groups (p = 0.0005, and p = 0.0000, respectively). In…

Malemedicine.medical_specialtyPathologyNeurologychemistry.chemical_elementtau ProteinsCentral nervous system diseaseDegenerative diseaseAlzheimer DiseaseInternal medicineBlood plasmamedicineDementiaHumansBiological PsychiatryAgedAged 80 and overDepressive DisorderAmyloid beta-PeptidesNeurodegenerationMercuryMiddle Agedmedicine.diseaseMercury (element)Psychiatry and Mental healthEndocrinologyNeurologychemistryLinear ModelsFemaleNeurology (clinical)Alzheimer's diseasePsychologyBiomarkersJournal of neural transmission (Vienna, Austria : 1996)
researchProduct

Associations of neuropsychiatric symptoms and antidepressant prescription with survival in Alzheimer's disease

2017

Objective Depression is associated with increased mortality in community samples. The use of antidepressant medication may also increase mortality, however, it is still unclear whether taking antidepressants before or after a diagnosis of dementia influences survival. Design Retrospective. Setting A cohort with a diagnosis of Alzheimer disease (AD) from a large mental health and dementia care database in South London, linked to hospitalization and mortality data. Participants Mild dementia (Mini-Mental State Examination ≥18/30) at the point of diagnosis. Measurements We ascertained antidepressant prescription, either in the 6 months before or after dementia diagnosis, and used the HoNOS65+,…

Malemedicine.medical_specialtyPediatricsDatabases FactualDementia; antidepressants; depression; mortalityKaplan-Meier EstimateNeuropsychological TestsRisk AssessmentSeverity of Illness Index03 medical and health sciencesSex Factors0302 clinical medicineAlzheimer DiseasemedicineHumansDementia030212 general & internal medicineMedical prescriptionRisk factorPsychiatryGeneral NursingDepression (differential diagnoses)AgedProportional Hazards ModelsRetrospective StudiesAged 80 and overDepressive Disorderbusiness.industryHealth PolicyHazard ratioAge FactorsGeneral MedicineMiddle AgedPrognosismedicine.diseaseSurvival AnalysismortalityAntidepressive AgentsConfidence intervalantidepressantsdepressionCohortFemaleDementiaGeriatrics and GerontologyAlzheimer's diseasebusinessdementia mortality030217 neurology & neurosurgery
researchProduct

Antidepressant-like activity of hyperforin and changes in BDNF and zinc levels in mice exposed to chronic unpredictable mild stress.

2019

Abstract Chronic unpredictable mild stress (CUMS) - a rodent model of depression mimics a variety of neurochemical and behavioral alterations similar to those seen in human depression. This study evaluated the antidepressant activity of hyperforin in the CUMS model using fluoxetine (FLX) as a reference drug. The antidepressant-like effects of hyperforin and FLX were evaluated in the tail suspension test (TST), forced swim test (FST), and splash test (SPT). CUMS induced an increase in immobility time in mice (pro-depressive effects) in the FST and TST. CUMS-induced changes were reversed by chronic treatment with hyperforin (2.5 and 5 mg/kg), as well as FLX (10 mg/kg). SPT results revealed a …

Malemedicine.medical_specialtyPhloroglucinolCREBHippocampus03 medical and health sciencesBehavioral Neurosciencechemistry.chemical_compoundMice0302 clinical medicineNeurochemicalInternal medicineFluoxetinemedicineHippocampus (mythology)Animals030304 developmental biology0303 health sciencesFluoxetineDepressive DisorderbiologyDepressionTerpenesBrain-Derived Neurotrophic FactorTail suspension testAntidepressive AgentsFrontal LobeMice Inbred C57BLHyperforinZincEndocrinologychemistrybiology.proteinAntidepressant030217 neurology & neurosurgeryStress Psychologicalmedicine.drugBehavioural despair testBehavioural brain research
researchProduct

Efficacy of a web-based intervention for improving psychosocial well-being in patients with implantable cardioverter-defibrillators: the randomized c…

2019

Abstract Aims Anxiety, depression, and reduced quality of life (QoL) are common in patients with implantable cardioverter-defibrillators (ICDs). Treatment options are limited and insufficiently defined. We evaluated the efficacy of a web-based intervention (WBI) vs. usual care (UC) for improving psychosocial well-being in ICD patients with elevated psychosocial distress. Methods and results This multicentre, randomized controlled trial (RCT) enrolled 118 ICD patients with increased anxiety or depression [≥6 points on either subscale of the Hospital Anxiety and Depression Scale (HADS)] or reduced QoL [≤16 points on the Satisfaction with Life Scale (SWLS)] from seven German sites (mean age 58…

Malemedicine.medical_specialtyPsychological interventionMixed anxiety-depressive disorderAnxiety030204 cardiovascular system & hematologyHospital Anxiety and Depression Scalelaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialQuality of lifelawmedicineHumansAgedCognitive Behavioral TherapyDepressionbusiness.industry030229 sport sciencesMiddle Agedmedicine.diseaseDefibrillators ImplantableDistressQuality of LifePhysical therapyAnxietyFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessPsychosocialInternet-Based InterventionEuropean Heart Journal
researchProduct

Association Between Citalopram Serum Levels and Clinical Improvement of Patients With Major Depression

2011

Imaging studies have shown that serum concentrations of the selective serotonin reuptake inhibitor citalopram correlate with serotonin transporter (5-HTT) occupancy in vivo. In patients with major depressive disorders treated with citalopram, 80% 5-HTT occupancy was considered to be necessary for maximal therapeutic effects, which requires citalopram serum concentrations of at least 50 ng/mL. The aim of this study was to compare treatment outcome in patients with citalopram serum concentrations greater than and less than 50 ng/mL after 7 days of treatment. This study included inpatients with acute major depressive disorder according to International Classification of Disease, 10th Revision …

Malemedicine.medical_specialtySerotonin reuptake inhibitorCitalopramCitalopramSeverity of Illness Indexbehavioral disciplines and activitiesGastroenterologyInternal medicinemental disordersSeverity of illnessmedicineHumansPharmacology (medical)Adverse effectDepressive Disorder Majormedicine.diagnostic_testTherapeutic effectLength of StayMiddle Agedmedicine.diseasePsychiatry and Mental healthTherapeutic drug monitoringAnesthesiaMajor depressive disorderFemaleDrug MonitoringReuptake inhibitorPsychologySelective Serotonin Reuptake Inhibitorsmedicine.drugJournal of Clinical Psychopharmacology
researchProduct

Rates and correlates of suicidal ideation among stroke survivors: a meta-Analysis

2017

BACKGROUND: A better understanding of the epidemiological impact of suicidal ideation after stroke is required to identify subjects needing personalised interventions. OBJECTIVE: The aim of this meta-analysis was to estimate rates and correlates of suicidal ideation among stroke survivors. METHODS: We searched via Ovid, Medline, Embase and PsycInfo from database inception until August 2016. Predefined outcomes were (1) rates of suicidal ideation based on random-effects pooled proportion and (2) relevant sociodemographic and clinical correlates, using random-effects odds ratio (OR) or standardised mean difference (SMD) for categorical and continuous variables, respectively. RESULTS: Fifteen …

Malemedicine.medical_specialtyStatistics as TopicMEDLINEPsychological interventionPsycINFOmeta-analysisurgery03 medical and health sciences0302 clinical medicineRecurrenceEpidemiologyOdds RatiomedicineHumansSurvivors030212 general & internal medicinePsychiatryStrokeSuicidal ideationSettore MED/25 - PsichiatriaAgedarts and humanitiesDepressive DisorderneurologyOdds ratioMiddle Agedmedicine.diseasestrokedepression; epidemiology; meta-analysis; stroke; suicidal ideation; surgery; arts and humanities ; neurology; psychiatry and mental healthmeta-analysissuicidal ideationpsychiatry and mental healthObservational Studies as TopicCross-Sectional StudiesMeta-analysisdepressionFemaleSettore MED/26 - NeurologiaepidemiologyNeurology (clinical)medicine.symptomPsychology030217 neurology & neurosurgeryClinical psychology
researchProduct

Smoking differently modifies suicide risk of affective disorders, substance use disorders, and social factors

2008

Abstract Background Although an association between smoking and suicide has repeatedly been shown, information about a modifying influence of smoking on other risk factors for suicide is lacking. Methods Axis I and Axis II disorders, sociodemographic factors, and tobacco use were assessed by a semi-structured interview including the Structured Clinical Interview for DSM-IV Axis I (SCID-I) and Personality Disorders (SCID-II) in 163 suicides (mean age 49.6 +/− 19.3 years; 64.4% men;) by psychological autopsy method and by personal interview in 396 living population-based control persons (mean age 51.6 +/− 17.0 years; 55.8% men). Results Smoking status (current smokers, lifetime non-smokers, a…

Malemedicine.medical_specialtySubstance-Related Disordersmedicine.medical_treatmentPoison controlComorbidityPersonality DisordersSuicide preventionRisk FactorsGermanyPrevalencemedicineHumansRisk factorPsychiatryDepression (differential diagnoses)Psychiatric Status Rating ScalesDepressive Disorder MajorMood DisordersResearchSmokingMiddle Agedmedicine.diseaseControl GroupsPersonality disordersDiagnostic and Statistical Manual of Mental DisordersSubstance abuseSuicidePsychiatry and Mental healthClinical PsychologySocioeconomic FactorsMood disordersCase-Control StudiesSmoking cessationFemaleSmoking CessationPsychologyClinical psychologyJournal of Affective Disorders
researchProduct

IMPROVEMENT OF PICTURE RECALL BY REPETITION IN PATIENTS WITH DEMENTIA OF ALZHEIMER TYPE

1997

The evidence for positive effects of repetition on recall performance in patients with dementia of Alzheimer type is equivocal. This may be due to the difference repetition conditions used. The aim of this study was therefore to evaluate the effects of different repetition modes on the improvement of recall performance in demented subjects. Twenty-four patients with Alzheimer type dementia and 24 control subjects with remitted depression were included in the study. Pictures were presented repeatedly using different presentation modes at a constant total presentation time. Free recall was tested repeatedly after different periods of delay (0-8 hours). Immediate and delayed list repetition si…

Malemedicine.medical_specialtyTime FactorsNeuropsychological TestsAudiologySensitivity and SpecificityDevelopmental psychologyAlzheimer DiseaseMemorymedicineHumansLearningIn patientMemory disorderGeriatric AssessmentAgedRecognition memoryPsychiatric Status Rating ScalesDepressive DisorderRecallRepetition (rhetorical device)Cognitive disordermedicine.diseasePsychiatry and Mental healthFree recallCase-Control StudiesFemaleGeriatrics and GerontologyAlzheimer's diseasePsychologyInternational Journal of Geriatric Psychiatry
researchProduct

Serum concentrations of hydroxybupropion for dose optimization of depressed patients treated with bupropion.

2014

Background Bupropion is a dopamine and norepinephrine reuptake inhibitor approved for the treatment of depression and smoking cessation. According to the recently published reviews, it is a candidate for therapeutic drug monitoring (TDM) to improve therapeutic outcomes and reduce risks of intolerability or intoxication. In practice, however, the use of TDM is limited due to the chemical instability of bupropion. This investigation sought to determine if the major, active, and chemically stable metabolite 4-hydroxybupropion is a suitable measure to guide antidepressant drug therapy with bupropion. Methods 4-Hydroxybupropion serum levels were measured using a newly developed and validated hig…

Malemedicine.medical_specialtyUrologyNorepinephrine reuptake inhibitorPharmacokineticsmedicineHumansPharmacology (medical)BupropionChromatography High Pressure LiquidRetrospective StudiesPharmacologyBupropionDepressive Disordermedicine.diagnostic_testbusiness.industryTherapeutic effectHydroxybupropionMiddle AgedTherapeutic drug monitoringArea Under CurveClinical Global ImpressionAntidepressantAntidepressive Agents Second-GenerationFemalebusinessmedicine.drugHalf-LifeTherapeutic drug monitoring
researchProduct

Symptoms of depression and anxiety predict mortality in patients undergoing oral anticoagulation: Results from the thrombEVAL study program

2015

Abstract Background/objectives Depression and anxiety are highly prevalent in cardiovascular patients. Therefore, we examined whether the 4-item Patient Health Questionnaire (PHQ-4, measuring symptoms of depression and anxiety) predicts all-cause mortality in outpatients with long-term oral anticoagulation (OAC). Methods The sample comprised n=1384 outpatients from a regular medical care setting receiving long-term OAC with vitamin K antagonists. At baseline, symptoms of anxiety and depression were assessed with the PHQ-4 and the past medical history was taken. The outcome was all-cause mortality in the 24month observation period. The median follow-up time was 13.3months. Results N=191 pati…

Malemedicine.medical_specialtyVitamin KSickness Impact ProfileSurveys and QuestionnairesInternal medicinemedicineHumansMass ScreeningMedical historyProspective StudiesScreening proceduresDepression (differential diagnoses)AgedAged 80 and overDepressive DisorderPast medical historybusiness.industryMortality rateHazard ratioAnticoagulantsMiddle AgedAnxiety DisordersPatient Health QuestionnaireCardiovascular DiseasesPhysical therapyAnxietyFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessInternational Journal of Cardiology
researchProduct